Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2018

Galassi TV, Jena PV, Shah J, Ao G, Molitor E, Bram Y, et al. An optical nanoreporter of endolysosomal lipid accumulation reveals enduring effects of diet on hepatic macrophages in vivo. Sci Transl Med. 2018;10(461).

Trindade AJ, Fan C, Cheung M, Greenberg RE. Endoscopic resection of an esophageal schwannoma. Dig Liver Dis. 2018;50(3):309.

Ramos JC, Sparano JA, Rudek MA, Moore PC, Cesarman E, Reid EG, et al. Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075). Clin Lymphoma Myeloma Leuk. 2018;18(3):180-190.e2.

Magro CM, Olson LC. Small cell lymphocytic variant of marginal zone lymphoma: A distinct form of marginal zone lymphoma derived from naïve B cells as a cutaneous counterpart to the naïve marginal zone lymphoma of splenic origin. Ann Diagn Pathol. 2018;34:116-121.

Scognamiglio T, Chen Y-. Beyond the Percentages of PD-L1-Positive Tumor Cells: Induced Versus Constitutive PD-L1 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma. Head Neck Pathol. 2018;12(2):221-229.

Alves CP, Dey-Guha I, Kabraji S, Yeh AC, Talele NP, Solé X, et al. AKT1 Quiescent Cancer Cells Promote Solid Tumor Growth. Mol Cancer Ther. 2018;17(1):254-263.

J Mulvey J, Magro C, Chadburn A. Resolution of a steroid-resistant, hypereosinophilic immune diathesis with mepolizumab and concomitant amelioration of a mixed thrombotic microangiopathy. Blood Cells Mol Dis. 2018;69:38-42.

Arenas MA, Whitsett TG, Aronova A, Henderson SA, LoBello J, Habra MA, et al. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma. Ann Surg Oncol. 2018;25(3):801-807.

Morrone KA, Pecker LH, Rand J, Davila J, Oyeku S, Little JA, et al. Association of silent infarcts in sickle cell anemia with decreased annexin A5 resistance. Blood Cells Mol Dis. 2018;69:53-56.

Bellazzo A, Di Minin G, Valentino E, Sicari D, Torre D, Marchionni L, et al. Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells. Cell Death Differ. 2018;25(7):1224-1238.